1
|
Taiariol L, Chaix C, Farre C, Moreau E. Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines? Chem Rev 2021; 122:340-384. [PMID: 34705429 DOI: 10.1021/acs.chemrev.1c00484] [Citation(s) in RCA: 63] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Over the years, click and bioorthogonal reactions have been the subject of considerable research efforts. These high-performance chemical reactions have been developed to meet requirements not often provided by the chemical reactions commonly used today in the biological environment, such as selectivity, rapid reaction rate, and biocompatibility. Click and bioorthogonal reactions have been attracting increasing attention in the biomedical field for the engineering of nanomedicines. In this review, we study a compilation of articles from 2014 to the present, using the terms "click chemistry and nanoparticles (NPs)" to highlight the application of this type of chemistry for applications involving NPs intended for biomedical applications. This study identifies the main strategies offered by click and bioorthogonal chemistry, with respect to passive and active targeting, for NP functionalization with specific and multiple properties for imaging and cancer therapy. In the final part, a novel and promising approach for "two step" targeting of NPs, called pretargeting (PT), is also discussed; the principle of this strategy as well as all the studies listed from 2014 to the present are presented in more detail.
Collapse
Affiliation(s)
- Ludivine Taiariol
- Université Clermont Auvergne, Imagerie Moléculaire et Stratégies Théranostiques, BP 184, F-63005 Clermont-Ferrand, France.,Inserm U 1240, F-63000 Clermont-Ferrand, France.,Centre Jean Perrin, F-63011 Clermont-Ferrand, France
| | - Carole Chaix
- Interfaces and Biosensors, UMR 5280, CNRS, F-69100 Villeurbanne, France.,Université de Lyon, CNRS, Université Claude Bernard Lyon 1, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, F-69100 Villeurbanne, France
| | - Carole Farre
- Interfaces and Biosensors, UMR 5280, CNRS, F-69100 Villeurbanne, France.,Université de Lyon, CNRS, Université Claude Bernard Lyon 1, Institut des Sciences Analytiques, UMR 5280, 5 rue de la Doua, F-69100 Villeurbanne, France
| | - Emmanuel Moreau
- Université Clermont Auvergne, Imagerie Moléculaire et Stratégies Théranostiques, BP 184, F-63005 Clermont-Ferrand, France.,Inserm U 1240, F-63000 Clermont-Ferrand, France.,Centre Jean Perrin, F-63011 Clermont-Ferrand, France
| |
Collapse
|
2
|
Sanjaya KC, Ranzoni A, Hung J, Blaskovich MAT, Watterson D, Young PR, Cooper MA. Flow-cytometry detection of fluorescent magnetic nanoparticle clusters increases sensitivity of dengue immunoassay. Anal Chim Acta 2020; 1107:85-91. [PMID: 32200905 DOI: 10.1016/j.aca.2020.02.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2019] [Revised: 01/03/2020] [Accepted: 02/04/2020] [Indexed: 01/10/2023]
Abstract
We report a flow-cytometry based method capable of detecting a range of analytes by monitoring the analyte-induced clustering of magnetic and fluorescent nanoparticles with flow cytometry. Using the dengue viral antigen (NS1) as an example, antibodies were conjugated to magnetic and fluorescent nanoparticles in a sandwich immunoassay format. These nanoparticles formed clusters when NS1 was present in a sample and the cluster formation was directly proportional to the concentration of antigen. Simultaneous flow cytometry measurement of cluster size, as detected by the forward scatter channel, combined with fluorescence intensity led to a reduction in the assay background signal, resulting in improved analytical sensitivity. We were able to detect 2.5 ng mL-1 of NS1 in serum samples by quantifying the clusters, a two-log fold improvement in the assay limit of detection over total fluorescence quantification alone.
Collapse
Affiliation(s)
- K C Sanjaya
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Andrea Ranzoni
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Jacky Hung
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Mark A T Blaskovich
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Daniel Watterson
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Paul R Young
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, 4072, QLD, Australia
| | - Matthew A Cooper
- Institute for Molecular Bioscience, 306 Carmody Road, The University of Queensland, Brisbane, 4072, QLD, Australia.
| |
Collapse
|
3
|
Uddin R, Nur-E-Habiba, Rena G, Hwu ET, Boisen A. New Evidence for the Mechanism of Action of a Type-2 Diabetes Drug Using a Magnetic Bead-Based Automated Biosensing Platform. ACS Sens 2017; 2:1329-1336. [PMID: 28776376 PMCID: PMC5613276 DOI: 10.1021/acssensors.7b00384] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
![]()
The mechanism of
action (MOA) of the first line type-2 diabetes
drug metformin remains unclear despite its widespread usage. However,
recent evidence suggests that the mitochondrial copper (Cu)-binding
action of metformin may contribute toward the drug’s MOA. Here,
we present a novel biosensing platform for investigating the MOA of
metformin using a magnetic microbead-based agglutination assay which
has allowed us to demonstrate for the first time the interaction between
Cu and metformin at clinically relevant low micromolar concentrations
of the drug, thus suggesting a potential pathway of metformin’s
blood-glucose lowering action. In this assay, cysteine-functionalized
magnetic beadswere agglutinated in the presence of Cu due to cysteine’s
Cu-chelation property. Addition of clinically relevant doses of metformin
resulted in disaggregation of Cu-bridged bead-clusters, whereas the
effect of adding a closely related but blood-glucose neutral drug
propanediimidamide (PDI) showed completely different responses to
the clusters. The entire assay was integrated in an automated microfluidics
platform with an advanced optical imaging unit by which we investigated
these aggregation–disaggregation phenomena in a reliable, automated,
and user-friendly fashion with total assay time of 17 min requiring
a sample (metformin/PDI) volume of 30 μL. The marked difference
of Cu-binding action between the blood-glucose lowering drug metformin
and its inactive analogue PDI thus suggests that metformin’s
distinctive Cu-binding properties may be required for its effect on
glucose homeostasis. The novel automated platform demonstrating this
novel investigation thus holds the potential to be utilized for investigating
significant and sensitive molecular interactions via magnetic bead-based
agglutination assay.
Collapse
Affiliation(s)
- Rokon Uddin
- Department
of Micro- and Nanotechnology, Technical University of Denmark, DTU Nanotech, Building 345 East, DK-2800 Kongens Lyngby, Denmark
| | - Nur-E-Habiba
- Department
of Chemistry and Bioengineering, Tampere University of Technology, 33720, Tampere, Finland
| | - Graham Rena
- Molecular
and Clinical Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, United Kingdom
| | - En-Te Hwu
- Institute
of Physics, Academia Sinica, Nankang, 11529 Taiwan
| | - Anja Boisen
- Department
of Micro- and Nanotechnology, Technical University of Denmark, DTU Nanotech, Building 345 East, DK-2800 Kongens Lyngby, Denmark
| |
Collapse
|
4
|
Lebani K, Jones ML, Watterson D, Ranzoni A, Traves RJ, Young PR, Mahler SM. Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay. PLoS One 2017; 12:e0180669. [PMID: 28683141 PMCID: PMC5500353 DOI: 10.1371/journal.pone.0180669] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2017] [Accepted: 06/19/2017] [Indexed: 01/01/2023] Open
Abstract
The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Non-structural protein 1 (NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay (ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability.
Collapse
Affiliation(s)
- Kebaneilwe Lebani
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
| | - Martina L. Jones
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland, Brisbane, Queensland, Australia
- * E-mail:
| | - Daniel Watterson
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia
- Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia
| | - Andrea Ranzoni
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia
| | - Renee J. Traves
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia
| | - Paul R. Young
- ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland, Brisbane, Queensland, Australia
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia
- Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia
| | - Stephen M. Mahler
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland, Brisbane, Queensland, Australia
| |
Collapse
|
5
|
Hassan MM, Ranzoni A, Phetsang W, Blaskovich MAT, Cooper MA. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria. Bioconjug Chem 2016; 28:353-361. [DOI: 10.1021/acs.bioconjchem.6b00494] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Marwa M. Hassan
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Andrea Ranzoni
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Wanida Phetsang
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Mark A. T. Blaskovich
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
| | - Matthew A. Cooper
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
| |
Collapse
|
6
|
Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection. Sci Rep 2015; 5:16145. [PMID: 26536916 PMCID: PMC4633614 DOI: 10.1038/srep16145] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2015] [Accepted: 10/07/2015] [Indexed: 12/12/2022] Open
Abstract
Dengue is a tropical vector-borne disease without cure or vaccine that progressively spreads into regions with temperate climates. Diagnostic tools amenable to resource-limited settings would be highly valuable for epidemiologic control and containment during outbreaks. Here, we present a novel low-cost automated biosensing platform for detection of dengue fever biomarker NS1 and demonstrate it on NS1 spiked in human serum. Magnetic nanoparticles (MNPs) are coated with high-affinity monoclonal antibodies against NS1 via bio-orthogonal Cu-free 'click' chemistry on an anti-fouling surface molecular architecture. The presence of the target antigen NS1 triggers MNP agglutination and the formation of nanoclusters with rapid kinetics enhanced by external magnetic actuation. The amount and size of the nanoclusters correlate with the target concentration and can be quantified using an optomagnetic readout method. The resulting automated dengue fever assay takes just 8 minutes, requires 6 μL of serum sample and shows a limit of detection of 25 ng/mL with an upper detection range of 20000 ng/mL. The technology holds a great potential to be applied to NS1 detection in patient samples. As the assay is implemented on a low-cost microfluidic disc the platform is suited for further expansion to multiplexed detection of a wide panel of biomarkers.
Collapse
|
7
|
Ranzoni A, den Hamer A, Karoli T, Buechler J, Cooper MA. Improved Immunoassay Sensitivity in Serum as a Result of Polymer-Entrapped Quantum Dots: ‘Papaya Particles’. Anal Chem 2015; 87:6150-7. [DOI: 10.1021/acs.analchem.5b00762] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Andrea Ranzoni
- Institute
for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, 4072, Australia
| | - Anniek den Hamer
- Institute
for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, 4072, Australia
| | - Tomislav Karoli
- Institute
for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, 4072, Australia
| | - Joseph Buechler
- ALERE Inc., 9975 Summers Ridge Road, San Diego, California 92121, United States
| | - Matthew. A. Cooper
- Institute
for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, 4072, Australia
| |
Collapse
|